Research Milestone

lycera

Lycera Achieves First Milestone in Merck Research Collaboration

Lycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.

WWJ Newsradio 950–12/21/2011

Follow

Get every new post delivered to your Inbox.

Join 1,974 other followers